Cargando…

Intermediate Vancomycin Susceptibility in a Community-associated MRSA Clone

We describe a case of treatment failure caused by a strain of USA300 community-associated methicillin-resistant Staphylococcus aureus (MRSA) with intermediate susceptibility to vancomycin and reduced susceptibility to daptomycin. The strain was isolated from the bone of a 56-year-old man with lumbar...

Descripción completa

Detalles Bibliográficos
Autores principales: Graber, Christopher J., Wong, Margaret K., Carleton, Heather A., Perdreau-Remington, Françoise, Haller, Barbara L., Chambers, Henry F.
Formato: Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2725904/
https://www.ncbi.nlm.nih.gov/pubmed/17552110
http://dx.doi.org/10.3201/eid1303.060960
_version_ 1782170541566722048
author Graber, Christopher J.
Wong, Margaret K.
Carleton, Heather A.
Perdreau-Remington, Françoise
Haller, Barbara L.
Chambers, Henry F.
author_facet Graber, Christopher J.
Wong, Margaret K.
Carleton, Heather A.
Perdreau-Remington, Françoise
Haller, Barbara L.
Chambers, Henry F.
author_sort Graber, Christopher J.
collection PubMed
description We describe a case of treatment failure caused by a strain of USA300 community-associated methicillin-resistant Staphylococcus aureus (MRSA) with intermediate susceptibility to vancomycin and reduced susceptibility to daptomycin. The strain was isolated from the bone of a 56-year-old man with lumbar osteomyelitis after a 6-week treatment course of vancomycin for catheter-associated septic thrombophlebitis.
format Text
id pubmed-2725904
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-27259042009-09-10 Intermediate Vancomycin Susceptibility in a Community-associated MRSA Clone Graber, Christopher J. Wong, Margaret K. Carleton, Heather A. Perdreau-Remington, Françoise Haller, Barbara L. Chambers, Henry F. Emerg Infect Dis Dispatch We describe a case of treatment failure caused by a strain of USA300 community-associated methicillin-resistant Staphylococcus aureus (MRSA) with intermediate susceptibility to vancomycin and reduced susceptibility to daptomycin. The strain was isolated from the bone of a 56-year-old man with lumbar osteomyelitis after a 6-week treatment course of vancomycin for catheter-associated septic thrombophlebitis. Centers for Disease Control and Prevention 2007-03 /pmc/articles/PMC2725904/ /pubmed/17552110 http://dx.doi.org/10.3201/eid1303.060960 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Graber, Christopher J.
Wong, Margaret K.
Carleton, Heather A.
Perdreau-Remington, Françoise
Haller, Barbara L.
Chambers, Henry F.
Intermediate Vancomycin Susceptibility in a Community-associated MRSA Clone
title Intermediate Vancomycin Susceptibility in a Community-associated MRSA Clone
title_full Intermediate Vancomycin Susceptibility in a Community-associated MRSA Clone
title_fullStr Intermediate Vancomycin Susceptibility in a Community-associated MRSA Clone
title_full_unstemmed Intermediate Vancomycin Susceptibility in a Community-associated MRSA Clone
title_short Intermediate Vancomycin Susceptibility in a Community-associated MRSA Clone
title_sort intermediate vancomycin susceptibility in a community-associated mrsa clone
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2725904/
https://www.ncbi.nlm.nih.gov/pubmed/17552110
http://dx.doi.org/10.3201/eid1303.060960
work_keys_str_mv AT graberchristopherj intermediatevancomycinsusceptibilityinacommunityassociatedmrsaclone
AT wongmargaretk intermediatevancomycinsusceptibilityinacommunityassociatedmrsaclone
AT carletonheathera intermediatevancomycinsusceptibilityinacommunityassociatedmrsaclone
AT perdreauremingtonfrancoise intermediatevancomycinsusceptibilityinacommunityassociatedmrsaclone
AT hallerbarbaral intermediatevancomycinsusceptibilityinacommunityassociatedmrsaclone
AT chambershenryf intermediatevancomycinsusceptibilityinacommunityassociatedmrsaclone